Status:
UNKNOWN
Evaluation of the Predictive Value of the Microvesicle Coagulo-lytic Balance in the Recurrence of Venous Thrombosis
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Venous Thromboembolism (VTE)
Eligibility:
All Genders
18+ years
Brief Summary
Venous thromboembolism (VTE) including deep vein thrombosis (DVT) and pulmonary embolism (PE) affects about 1,200,000 individuals each year in Europe. About 50% of VTE are unprovoked and 20% of these ...
Eligibility Criteria
Inclusion
- adult patients with a VTE history with at least 3 months of anticoagulant treatment.
Exclusion
- \-
Key Trial Info
Start Date :
September 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2019
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03265054
Start Date
September 1 2017
End Date
September 1 2019
Last Update
August 29 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assistance Publique Hôpitaux de Marseille
Marseille, France